Nephros (NEPH) Net Equity Issued and Repurchased (2011 - 2020)

Nephros has reported Net Equity Issued and Repurchased for 8 years, with the latest figure at $4.7 million in Q4 2020.

• On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $4.7 million in Q4 2020; TTM through Dec 2020 was $11.5 million, a 53.6% decrease from a year earlier, with the FY2020 full-year figure at $11.5 million, up 474.9% from the prior year.
• Net Equity Issued and Repurchased was $4.7 million for Q4 2020 at Nephros, down from $6.8 million in the prior quarter.
• The five-year high for Net Equity Issued and Repurchased was $21.0 million in Q3 2019, with the low at -$8000.0 in Q2 2017.
• Average Net Equity Issued and Repurchased over 4 years is $5.5 million, with a median of $3.7 million recorded in 2018.
• The largest YoY upside for Net Equity Issued and Repurchased was 46093.12% in 2018 against a maximum downside of 28.05% in 2018.
• Over 4 years, Net Equity Issued and Repurchased stood at -$8000.0 in 2017, then surged by 46093.12% to $3.7 million in 2018, then jumped by 470.74% to $21.0 million in 2019, then slumped by 77.71% to $4.7 million in 2020.
• The last three Net Equity Issued and Repurchased figures came in at $4.7 million (Q4 2020), $6.8 million (Q1 2020), and $21.0 million (Q3 2019), per Business Quant data.